Vilsure M Tablet

Oral tablet; take exactly as prescribed, usually with meals to reduce stomach upset. Swallow whole with water; do not crush/chew unless advised. Follow diet/exercise plan and monitor blood glucose regularly.

Metformin reduces glucose production in the liver and improves insulin sensitivity, lowering insulin resistance. Vildagliptin is a DPP-4 inhibitor that increases incretin hormones (GLP‑1, GIP), leading to increased insulin release and reduced glucagon in a glucose‑dependent manner.

Prescription medicine. Risk of lactic acidosis with metformin (rare but serious): seek urgent care for rapid breathing, severe weakness, muscle pain, unusual sleepiness, abdominal pain. Avoid/use with caution in kidney impairment; dose adjustment or discontinuation may be needed based on eGFR. Use caution in liver disease, dehydration, severe infection, hypoxia, heart failure, and in the elderly. Temporarily stop metformin before/at time of iodinated contrast imaging and during major surgery as advised by doctor. Hypoglycaemia risk increases if used with insulin/sulfonylureas; monitor glucose. Pancreatitis has been reported with DPP‑4 inhibitors—stop and seek care if severe persistent abdominal pain occurs.

Alcohol (increases lactic acidosis risk), iodinated contrast media, insulin and sulfonylureas (increased hypoglycaemia risk), diuretics and ACE inhibitors/ARBs (may affect renal function and metformin levels), corticosteroids and thiazide diuretics (may raise glucose), cimetidine (may increase metformin levels), beta‑blockers (may mask hypoglycaemia symptoms)

Store below 25°C in a cool, dry place away from moisture and direct light. Keep in original strip and out of reach of children.

Galvus Met 50/500 Tablet, Jalra-M 50/500 Tablet, Zomelis 50/500 Tablet, Vilda M 50/500 Tablet, Vildamet 50/500 Tablet